(Total Views: 307)
Posted On: 03/11/2022 10:55:49 AM
Post# of 53

$CAPR News Article - The Lancet Publishes Positive Results from Capricor Therapeutics' Phase 2 Study Evaluating CAP-1002 in Late-Stage Duchenne Muscular Dystrophy https://marketwirenews.com/news-releases/the-...26977.html


My Twitter: WhyteStocks